See more : Clarke Inc. (CLKFF) Income Statement Analysis – Financial Results
Complete financial analysis of Nureca Limited (NURECA.BO) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Nureca Limited, a leading company in the Medical – Devices industry within the Healthcare sector.
- Taiwan Paiho Limited (9938.TW) Income Statement Analysis – Financial Results
- PAOS INDUSTRIES LIMITED (PAOS.BO) Income Statement Analysis – Financial Results
- Kolmar Korea Holdings Co., Ltd. (024720.KS) Income Statement Analysis – Financial Results
- Palamina Corp. (PA.V) Income Statement Analysis – Financial Results
- ESOTIQ & Henderson S.A. (EAH.WA) Income Statement Analysis – Financial Results
Nureca Limited (NURECA.BO)
About Nureca Limited
Nureca Limited provides home healthcare and wellness products in India. The company offers chronic disease products, such as nebulizers, blood pressure monitors, finger pulse oximeters, connected products, glucose meters, and thermometers; orthopedic products, including massagers, pain management products, posture correctors, and rehabilitation products; and humidifiers and steamers, personal scales, massagers, yoga and exercise products, fitness tracking products, and dental and personal care products. It provides mother and baby care products comprising baby feeding products, carry cots, baby skincare products, and bottle warmers and steamers; nutritional supplements and weight management products; and ECG products, blood pressure monitors, glucometer, fitness trackers, and smart weighing scales. It offers its products under the Dr Trust, Dr Physio, and Trumom brands. The company markets its products through e-commerce players, distributors, and retailers. Nureca Limited was incorporated in 2016 and is based in Chandigarh, India.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 919.28M | 1.11B | 2.56B | 2.13B | 994.26M | 618.97M | 200.51M | 198.00K |
| Cost of Revenue | 607.86M | 755.31M | 1.33B | 994.82M | 646.03M | 401.53M | 111.10M | 173.14K |
| Gross Profit | 311.42M | 357.92M | 1.23B | 1.14B | 348.23M | 217.44M | 89.41M | 24.86K |
| Gross Profit Ratio | 33.88% | 32.15% | 48.10% | 53.39% | 35.02% | 35.13% | 44.59% | 12.56% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 22.10M | 34.29M | 52.16M | 8.58M | 9.14M | 1.55M | 670.00K | 0.00 |
| Selling & Marketing | 101.93M | 35.98M | 117.38M | 95.88M | 31.31M | 23.12M | 2.49M | 0.00 |
| SG&A | 124.03M | 70.27M | 169.54M | 104.46M | 40.45M | 24.67M | 3.16M | 0.00 |
| Other Expenses | 189.10M | 2.57M | 2.52M | 980.00K | 610.00K | 10.00K | -690.00K | 0.00 |
| Operating Expenses | 313.13M | 529.09M | 681.19M | 517.60M | 255.03M | 127.46M | 45.72M | 21.37K |
| Cost & Expenses | 919.28M | 1.28B | 2.01B | 1.51B | 901.06M | 528.99M | 156.82M | 194.51K |
| Interest Income | 38.89M | 42.21M | 52.40M | 17.57M | 200.00K | 1.12M | 0.00 | 0.00 |
| Interest Expense | 4.89M | 3.36M | 4.36M | 14.78M | 4.23M | 1.12M | 30.00K | 0.00 |
| Depreciation & Amortization | 23.62M | 23.88M | 14.82M | 4.22M | 3.74M | 570.00K | 60.00K | 10.01K |
| EBITDA | 2.41M | -79.04M | 632.04M | 636.83M | 97.55M | 91.41M | 43.75M | 19.86K |
| EBITDA Ratio | 0.26% | -9.15% | 24.66% | 30.60% | 9.46% | 14.56% | 21.60% | 10.03% |
| Operating Income | 1.05M | -162.51M | 566.98M | 622.88M | 93.72M | 89.98M | 43.69M | 9.85K |
| Operating Income Ratio | 0.11% | -14.60% | 22.19% | 29.18% | 9.43% | 14.54% | 21.79% | 4.97% |
| Total Other Income/Expenses | -26.49M | 56.23M | -393.15M | -370.56M | -7.12M | -1.57M | -460.00K | -6.36K |
| Income Before Tax | -25.44M | -107.42M | 609.81M | 623.33M | 86.08M | 88.41M | 43.23M | 3.49K |
| Income Before Tax Ratio | -2.77% | -9.65% | 23.86% | 29.20% | 8.66% | 14.28% | 21.56% | 1.76% |
| Income Tax Expense | -7.50M | -24.92M | 160.21M | 159.59M | 22.13M | 26.15M | 12.11M | 1.04K |
| Net Income | -17.94M | -82.50M | 449.60M | 463.74M | 63.95M | 62.26M | 31.12M | 2.45K |
| Net Income Ratio | -1.95% | -7.41% | 17.59% | 21.73% | 6.43% | 10.06% | 15.52% | 1.24% |
| EPS | -1.79 | -8.25 | 44.96 | 62.04 | 6.40K | 8.89 | 4.45 | 0.09 |
| EPS Diluted | -1.79 | -8.25 | 44.96 | 62.04 | 6.40K | 8.73 | 4.36 | 0.09 |
| Weighted Avg Shares Out | 10.02M | 10.00M | 10.00M | 7.48M | 10.00K | 7.00M | 7.00M | 28.57K |
| Weighted Avg Shares Out (Dil) | 10.00M | 10.00M | 10.00M | 7.48M | 10.00K | 7.13M | 7.13M | 28.57K |
Source: https://incomestatements.info
Category: Stock Reports